Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Molecular Pharmaceutics|August 17, 2016
Comparative Evaluation of Affibody Molecules for Radionuclide Imaging of in Vivo Expression of Carbonic Anhydrase IXJavad Garousi, Hadis Honarvar, Ken G Andersson, et al.
Molecules (Basel, Switzerland)|October 17, 2020
Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1Anzhelika Vorobyeva, Ekaterina Bezverkhniaia, Elena Konovalova, et al.
Cancer Research|August 23, 2015
ADAPT, a Novel Scaffold Protein-Based Probe for Radionuclide Imaging of Molecular Targets That Are Expressed in Disseminated CancersJavad Garousi, Sarah Lindbo, Johan Nilvebrant, et al.
Molecular Pharmaceutics|November 22, 2017
Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor OverexpressionDominik Summer, Javad Garousi, Maryam Oroujeni, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Nanoparticles targeting the intestinal Fc receptor enhance intestinal cellular trafficking of semaglutideSoraia Pinto, Mahya Hosseini, Stephen T Buckley, et al.
International Journal of Molecular Sciences|May 13, 2020
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1Anzhelika Vorobyeva, Elena Konovalova, Tianqi Xu, et al.
Pharmaceutics|November 27, 2021
Targeting HER2 Expressing Tumors with a Potent Drug Conjugate Based on an Albumin Binding Domain-Derived Affinity ProteinJavad Garousi, Haozhong Ding, Emma von Witting, et al.
Amino Acids|May 6, 2018
Influence of composition of cysteine-containing peptide-based chelators on biodistribution of 99mTc-labeled anti-EGFR affibody moleculesMaryam Oroujeni, Ken G Andersson, Xenia Steinhardt, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 15, 2019
Selection of the optimal macrocyclic chelators for labeling with 111In and 68Ga improves contrast of HER2 imaging using engineered scaffold protein ADAPT6Emma von Witting, Javad Garousi, Sarah Lindbo, et al.
Pharmaceutics|April 30, 2020
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo BiodistributionHaozhong Ding, Mohamed Altai, Wen Yin, et al.
Pageof 5